Compare Fubotv Inc (FUBO) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fubotv Inc vs 10X Genomics Inc — how do they compare? Fubotv Inc trades at $9.67 (market cap $1.06B), while 10X Genomics Inc trades at $58.53 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 7.2× Fubotv Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Fubotv Inc nearer its low. Which is the better fit depends on your goals.
| FUBO | TXG | |
|---|---|---|
Market Cap | $1.06B | $7.61B |
Sector | Technology | Health |
52-Week High | $54.72 | $58.57 |
52-Week Low | $8.09 | $11.34 |
Enterprise Value | $1.23B | $7.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUBO trades at $9.36, up 1.08% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with revenue growing to $1.62B in 2024 and projected net income turning positive at $123M for 2025. Recent CEO transition to former Disney executive Alisa Bowen and partnerships with major media companies signal strategic repositioning.
While valuation metrics appear attractive with P/E of 2.53 and P/S of 0.19, the stock faces execution risks in achieving profitability targets. Analyst consensus is mixed with 46.7% buy ratings and $15.33 price target, representing significant upside potential if the company can deliver on its EBITDA growth roadmap.
TXG trades at $58.57, up 12.57% in 24 hours, reflecting strong momentum. The stock is technically bullish with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and revenue growth, yet remains unprofitable with a negative net income margin. Recent news highlights collaborations and acquisitions expanding its genomic capabilities.
Outlook is mixed; analyst consensus is neutral with a $46 price target below current levels, indicating caution despite recent beats. Key risks include sustained losses and competitive pressures, but operational cash flow growth and strategic expansions offer potential upside for patient investors focused on long-term biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
